ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 621322 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 621322; 2) Community: the network communities that were significantly associated with the response to NSC 621322; 3) Molecule: the relationships between components within communities and NSC 621322; 4) MDR: the compounds that were significantly associated with the NSC 621322.

NSC Compound Enrichment Correlation
NSC 274548 Gold, [.mu.-[[5,5'-methylenebis[1H-tetrazolato]](2-)-N(1):N(1')]]bis(triphenylphosphine)di- 0.0171439890681608 0.35208041
NSC 320951 Bishelenalinyl malonate 0.0171439890681608 -0.029915114
NSC 335663 ACETYLROLANDROLIDE 0.0171439890681608 0.10637983
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0171439890681608 0.25409886
NSC 36768 Null 0.0171439890681608 0.036702748
NSC 58906 9H-Purine, 6-[(o-chlorobenzyl)thio]-9-(2-chloroethyl)- (8CI) 0.0171439890681608 0.091787095
NSC 610459 Camptothecin Derivative 0.0171439890681608 0.15594459
NSC 639174 Camptothecin Derivative 0.0171439890681608 0.11621749
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.0171439890681608 -0.0035326865
NSC 675003 Benzofuran-3-carboxylic acid, 2,3-dihydro-7-hydroxy- 2-(3,4-dihydroxyphenyl)-5-(3-methoxy-3-oxo-1-propen-1-yl)-, methyl ester, stereoisomer 0.0171439890681608 0.317179
Total:83  Current:32    [First] [Prev] [Next] [Last]